| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000031075 |
| Receipt No. | R000035489 |
| Scientific Title | Effects of remote feedback and self-monitoring intervention using pedometer on physical activity in patients with Parkinson's disease : A pilot study |
| Date of disclosure of the study information | 2018/01/31 |
| Last modified on | 2022/02/03 (Ver. 3) |
| Basic information | ||
| Public title | Effects of remote feedback and self-monitoring intervention using pedometer on physical activity in patients with Parkinson's disease : A pilot study | |
| Acronym | Effects of remote feedback and self-monitoring intervention on physical activity in patients with Parkinson's disease : A pilot study | |
| Scientific Title | Effects of remote feedback and self-monitoring intervention using pedometer on physical activity in patients with Parkinson's disease : A pilot study | |
| Scientific Title:Acronym | Effects of remote feedback and self-monitoring intervention on physical activity in patients with Parkinson's disease : A pilot study | |
| Region |
|
|
| Condition | |||
| Condition | Parkinson's disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The study tests the effects of remote feedback and self-management intervention on the physical activity, physical, mental function and Parkinson's symptoms in patients with Parkinson's diseases. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | (1) step counts at pre and post intervention (6 month) |
| Key secondary outcomes | (1) indicator of Parkinson's disease symptoms (motor symptoms, non-motor symptoms)
(2) drug regimen (3) cognitive function (attention, executive function, processing speed, etc.) (4) physical and mental performance and physical activity (5) psychological outcomes (6) daily life performance outcomes (7) biomarker |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control group: once-monthly Provide educational information for 6 months | |
| Interventions/Control_2 | Feedback and self-monitoring group: once-monthly pedometer-based step counts goal setting (5% increase) program and Provide educational information for 6 months | |
| Interventions/Control_3 | Feedback and self-monitoring group: once-monthly pedometer-based step counts goal setting (10% increase) program and Provide educational information for 6 months | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | For those who meet all of the following
(1) Diagnosed as Parkinson's disease based on UK Parkinson's Disease Society Brain Bank criteria (2) Stable antiparkinson drug regimen for at least 4 weeks prior to study entry (3) Stages <=3 in the ON state for Modified Hoehn and Yahr Scale (4) People who have given written consent |
|||
| Key exclusion criteria | Exclude any person who also corresponds to one of the following
(1) History of severe neurological diseases such as dementia, visual impairment, psychiatric disorders (2) Those who have severe cardiopulmonary disorder (3) Walking in daily life is not independent (4) People who are in the Investigator's judgment unlikely to comply with medical regimens or study requirements |
|||
| Target sample size | 45 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Fukuoka University | ||||||
| Division name | Department of Neurology | ||||||
| Zip code | 814-0180 | ||||||
| Address | 7-45-1 Nanakuma, Jonan-ku, Fukuoka-city, Fukuoka, Japan | ||||||
| TEL | 092-801-1011 | ||||||
| tsuboi@cis.fukuoka-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Fukuoka University Graduate School of Medicine | ||||||
| Division name | Department of Neurology and Neurological Science | ||||||
| Zip code | 814-0180 | ||||||
| Address | 7-45-1 Nanakuma, Jonan-ku, Fukuoka-city, Fukuoka, Japan | ||||||
| TEL | 092-801-1011 | ||||||
| Homepage URL | |||||||
| nagaki.fukuoka.university@gmail.com | |||||||
| Sponsor | |
| Institute | Department of Neurology, Fukuoka university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Fukuoka University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Fukuoka university Review Board |
| Address | 7-45-1 Nanakuma, Jonan-ku, Fukuoka-city, Fukuoka, Japan |
| Tel | 092-801-1011 |
| fu-merb-bigvan@fukuoka-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福岡大学病院(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035489 |